tetano
Editor, Senior Moderator
Wien Klin Wochenschr
. 2020 Dec 8.
doi: 10.1007/s00508-020-01776-w. Online ahead of print.
COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease
Michael Eder[SUP] 1 [/SUP], Robert Strassl[SUP] 2 [/SUP], Johannes Kl?ger[SUP] 3 [/SUP], Christof Aigner[SUP] 1 [/SUP], Florian Thalhammer[SUP] 4 [/SUP], Željko Kikić[SUP] 5 [/SUP]
Affiliations
Abstract
In this case report we present a rare case of a patient with multiple risk factors for severe coronavirus disease (COVID 19) in whom intensive glucocorticoid treatment due to incipient nephrotic syndrome coincided with SARS-CoV‑2 infection. Despite this high baseline risk profile and the use of glucocorticoids the patient developed only mild disease including IgG SARS-CoV‑2 seroconversion.
Keywords: Coronavirus; Glomerulonephritis; Hyperinflammatory syndrome; Immunosuppression; Kidney disease.
. 2020 Dec 8.
doi: 10.1007/s00508-020-01776-w. Online ahead of print.
COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease
Michael Eder[SUP] 1 [/SUP], Robert Strassl[SUP] 2 [/SUP], Johannes Kl?ger[SUP] 3 [/SUP], Christof Aigner[SUP] 1 [/SUP], Florian Thalhammer[SUP] 4 [/SUP], Željko Kikić[SUP] 5 [/SUP]
Affiliations
- PMID: 33289854
- DOI: 10.1007/s00508-020-01776-w
Abstract
In this case report we present a rare case of a patient with multiple risk factors for severe coronavirus disease (COVID 19) in whom intensive glucocorticoid treatment due to incipient nephrotic syndrome coincided with SARS-CoV‑2 infection. Despite this high baseline risk profile and the use of glucocorticoids the patient developed only mild disease including IgG SARS-CoV‑2 seroconversion.
Keywords: Coronavirus; Glomerulonephritis; Hyperinflammatory syndrome; Immunosuppression; Kidney disease.